文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

长链非编码 RNA SChLAP1 通过 miR-524-5p/HMGA2 轴调控三阴性乳腺癌细胞的增殖。

Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524‑5p/HMGA2 axis.

机构信息

Department of Breast Surgery, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi 030013, P.R. China.

Department of Rheumatism and Immunology, Second Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.

出版信息

Mol Med Rep. 2021 Jun;23(6). doi: 10.3892/mmr.2021.12085. Epub 2021 Apr 13.


DOI:10.3892/mmr.2021.12085
PMID:33846810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8060801/
Abstract

Long non‑coding RNA (lncRNA) second chromosome locus associated with prostate‑1 (SChLAP1), also named LINC00913, has been reported to accelerate the carcinogenesis of prostate cancer. The aim of this study was to explore the role and mechanism of SChLAP1 in triple negative breast cancer (TNBC). The expression of SChLAP1 in TNBC tissues and cells was determined by reverse transcription quantitative PCR. The effects of SChLAP1 on the growth of TNBC cells was evaluated by detecting cell viability, colony formation and apoptosis. The present study determined that SChLAP1 was upregulated in TNBC tissues and was associated with the long‑distant lymph node metastasis of patients with TNBC. Knockdown of SChLAP1 significantly inhibited cell viability and colony formation, and triggered apoptosis of TNBC cells. Bioinformatics analysis suggested that SChLAP1 acted as a sponge of microRNA (miR)‑524‑5p and negatively modulated the expression of miR‑524‑5p. An inverse correlation was also identified between the expression levels of SChLAP1 and miR‑524‑5p in TNBC tissues. Furthermore, the results demonstrated that SChLAP1 interacted with miR‑524‑5p, and subsequently regulated the expression level of High Mobility Group AT‑Hook 2 (HMGA2) in TNBC cells. It was also found that the overexpression of HMGA2 rescued the suppressed viability of TNBC cells induced by SChLAP1 knockdown. In conclusion, the present findings demonstrated that SChLAP1 modulated the malignant tumor behaviors of TNBC cells by regulating HMGA2 and subsequently restraining miR‑524‑5p.

摘要

长链非编码 RNA(lncRNA)第二染色体位置与前列腺-1(SChLAP1)相关,也称为 LINC00913,已被报道可加速前列腺癌的癌变。本研究旨在探讨 SChLAP1 在三阴性乳腺癌(TNBC)中的作用和机制。通过逆转录定量 PCR 测定 TNBC 组织和细胞中 SChLAP1 的表达。通过检测细胞活力、集落形成和细胞凋亡来评估 SChLAP1 对 TNBC 细胞生长的影响。本研究确定 SChLAP1 在 TNBC 组织中上调,并与 TNBC 患者的远处淋巴结转移有关。SChLAP1 的敲低显著抑制了 TNBC 细胞的活力和集落形成,并触发了 TNBC 细胞的凋亡。生物信息学分析表明,SChLAP1 作为 microRNA(miR)-524-5p 的海绵,并负调控 miR-524-5p 的表达。还发现 SChLAP1 在 TNBC 组织中的表达水平与 miR-524-5p 呈负相关。此外,研究结果表明 SChLAP1 与 miR-524-5p 相互作用,进而调节 TNBC 细胞中高迁移率族 AT 钩 2(HMGA2)的表达水平。还发现,HMGA2 的过表达挽救了 SChLAP1 敲低诱导的 TNBC 细胞活力的抑制。总之,本研究结果表明,SChLAP1 通过调节 HMGA2 并抑制 miR-524-5p 来调节 TNBC 细胞的恶性肿瘤行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/f33fe44d7c72/mmr-23-06-12085-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/97a4b2c1a1fd/mmr-23-06-12085-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/fcfe13601bdf/mmr-23-06-12085-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/c31904bedf8b/mmr-23-06-12085-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/8a8b25f32292/mmr-23-06-12085-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/f33fe44d7c72/mmr-23-06-12085-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/97a4b2c1a1fd/mmr-23-06-12085-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/fcfe13601bdf/mmr-23-06-12085-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/c31904bedf8b/mmr-23-06-12085-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/8a8b25f32292/mmr-23-06-12085-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfdb/8060801/f33fe44d7c72/mmr-23-06-12085-g04.jpg

相似文献

[1]
Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524‑5p/HMGA2 axis.

Mol Med Rep. 2021-6

[2]
Long Noncoding RNA LINC02163 Accelerates Malignant Tumor Behaviors in Breast Cancer by Regulating the MicroRNA-511-3p/HMGA2 Axis.

Oncol Res. 2020-12-10

[3]
Long Noncoding RNA SChLAP1 Accelerates the Proliferation and Metastasis of Prostate Cancer via Targeting miR-198 and Promoting the MAPK1 Pathway.

Oncol Res. 2017-5-11

[4]
LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.

Exp Cell Res. 2020-11-15

[5]
Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.

Biomed Pharmacother. 2018-5-25

[6]
LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p.

Aging (Albany NY). 2021-8-10

[7]
LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.

Biochem Biophys Res Commun. 2020-4-16

[8]
Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.

Cell Cycle. 2019-8-15

[9]
LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.

Cancer Med. 2019-6-18

[10]
Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer.

Biomed Pharmacother. 2017-11-24

引用本文的文献

[1]
Uncarboxylated osteocalcin induced miR-143-3p targets SP7 and activates PI3K/Akt signaling in TNBC cells to promote invasion and migration.

Transl Oncol. 2025-3

[2]
The emerging role and mechanism of HMGA2 in breast cancer.

J Cancer Res Clin Oncol. 2024-5-16

[3]
Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer.

Ann Transl Med. 2022-12

[4]
Long Noncoding RNA Mediated Regulation in Human Embryogenesis, Pluripotency, and Reproduction.

Stem Cells Int. 2022-1-22

[5]
Whole-genome-scale identification of novel non-protein-coding RNAs controlling cell proliferation and survival through a functional forward genetics strategy.

Sci Rep. 2022-1-7

本文引用的文献

[1]
Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies.

Int J Environ Res Public Health. 2020-3-20

[2]
LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.

Biomed Pharmacother. 2020-2-10

[3]
Triple negative breast cancer: A thorough review of biomarkers.

Crit Rev Oncol Hematol. 2019-12-20

[4]
Comprehensive analysis of dysregulated lncRNAs and their competing endogenous RNA network in triple-negative breast cancer.

Int J Biol Macromol. 2019-12-26

[5]
Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review.

BMC Cancer. 2019-11-8

[6]
Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer.

Biomolecules. 2019-11-2

[7]
MicroRNA-524-5p suppresses cell proliferation and promotes cell apoptosis in gastric cancer by regulating CASP3.

Eur Rev Med Pharmacol Sci. 2019-9

[8]
HMGA and Cancer: A Review on Patent Literatures.

Recent Pat Anticancer Drug Discov. 2019

[9]
miRDB: an online database for prediction of functional microRNA targets.

Nucleic Acids Res. 2020-1-8

[10]
Long Noncoding RNA Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-κB Signaling.

Clin Cancer Res. 2019-9-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索